ALEXIS WAHLEN: Open Payments
NPI 1194303784 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,509 in 118 payments from 17 companies in 2025. Trend: 2023 $3,129 · 2024 $4,199 · 2025 $4,509
Food & beverage: $4,202Education: $307
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 22 | $1,278 |
| Merck Sharp & Dohme LLC | 19 | $531 |
| United Therapeutics Corporation | 16 | $488 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $360 |
| AstraZeneca Pharmaceuticals LP | 7 | $345 |
| CVRx, Inc. | 13 | $306 |
| ABIOMED | 7 | $288 |
| ENDOTRONIX, INC. | 1 | $186 |
| Stryker Corporation | 2 | $184 |
| E.R. Squibb & Sons, L.L.C. | 5 | $174 |
Products named: UPTRAVI, WINREVAIR, Tyvaso, Adempas, Barostim Neo System, OPSUMIT, WAINUA, CORDELLA PULOMONARY ARTERY PRESSURE SENSOR.
Industry payments across TX — which companies pay providers there.
